Sangamo Therapeutics Selects Successful Bidders Following Competitive Asset Auction

Additional information about the Chapter 11 reorganization and asset sales is available through Sangamo's noticing agent at https://www.veritaglobal.net/SangamoTherapeutics.

Executive Leadership Team

Nikunj Jain

Interim Chief Financial Officer

Mr. Jain has served as the Company’s Interim Chief Financial Officer since February 2026, prior to which he served as the Company’s Vice President, Finance and Corporate Controller since September 2021. Earlier in his career, Mr. Jain held roles of increasing responsibility at Deloitte & Touche LLP in both the United States and India.  Mr. Jain received a Bachelor of Commerce degree from Mahatma Jyotibha Phule Rohilkhand University in Bareilly, India, and is a Chartered Accountant in India and a Certified Public Accountant in California (inactive).